IsaPD has been shown to add a year of life for patients with an incurable form of blood cancer, myeloma, but in June it was decided that it was not value for money. IsaPD has been shown to add a year of life for patients with an incurable form of blood cancer, myeloma, but in June it was decided that it was not value for money.
Watchdog to review its rejection of life-extending blood cancer drug that has been shown to add a year of life for patients
